Basel, Switzerland

Michael Wiedmann

This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Wiedmann. Retrieved from https://idiyas.com/inventor/michael-wiedmann-wf8q05vi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Michael Wiedmann

Introduction

Michael Wiedmann is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of affinity chromatography, particularly through his innovative patent. His work is recognized for its potential to enhance the efficiency of protein purification processes.

Latest Patents

Michael Wiedmann holds a patent titled "Method for the reduction of host cell proteins in affinity chromatography." This patent addresses a critical challenge in the biopharmaceutical industry, aiming to improve the purity of therapeutic proteins by minimizing unwanted host cell proteins during purification.

Career Highlights

Wiedmann is currently employed at Genentech, Inc., a leading biotechnology company known for its pioneering work in the development of innovative medicines. His role at Genentech allows him to apply his expertise in chromatography and contribute to the advancement of biopharmaceutical technologies.

Collaborations

Throughout his career, Michael has collaborated with esteemed colleagues, including Paul McDonald and Richard St John. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of cutting-edge solutions in the field of biotechnology.

Conclusion

Michael Wiedmann's contributions to affinity chromatography and his innovative patent demonstrate his commitment to advancing biopharmaceutical processes. His work at Genentech, along with his collaborations, highlights the importance of teamwork in driving innovation in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…